The cancer drug ads that get oncologists' attention online are informative and use clear, eye-catching designs. That’s ZoomRx ...
The prog­no­sis is poor for metasta­t­ic cas­tra­tion-re­sis­tant prostate can­cer (mCR­PC) pa­tients. No­var­tis wants to ...
Horizon Therapeutics announced last week that it was in talks with three pharmaceutical giants that could take over the ...
A biotech centered on treating fibrosis — born out of Mass General and Brigham and Women's Hospital — has received a ...
The first gen­er­a­tion of per­son­al­ized CAR-T ther­a­pies made big waves in the treat­ment of lym­phoma for their ...
Affinia Therapeutics has ditched its plans to go public in a relatively closed-door market that has not favored Nasdaq debuts ...
After co-founding two biotechs off virus-based therapies, one for pain and one for cancer, Ken Greenberg decided to go in a ...
The chikun­gun­ya virus met its match in Val­ne­va’s vac­cine can­di­date, VLA1553, ac­cord­ing to da­ta from an an­ti­body ...
TherapeuticsMD, a women’s health company whose one-time billion-dollar valuation seems a distant memory as its blockbuster ...
As the global biologics market is expected to hit nearly the half-trillion-dollar mark this year, new JAMA research points to ...
It is no secret that drug shortages have been prevalent in 2022. Several major drug products, such as amoxicillin and ...
More than two and a half years into the pandemic, Johnson & Johnson wants to remind people that nurses are much more than ...